MGC Pharmaceuticals acquires AI software to fast-track ZAM Medical Data App

MGC Pharmaceuticals’ Roby Zomer joins Proactive to talk about acquiring 40% of ZAM Software Limited (ZSL) to help fast-track the ZAM Medical Data App.

The app is set to launch in the third quarter of 2022 following a closed launch to collect data from 100 patients enrolled through MGC Pharma’s Australian tele-health business, Medicinal Cannabis Clinics (MCC).

The ZAM App is designed to provide tailored medical information to the patient alongside their health practitioner.

You might like

© 2022 The Latest StockMarket News and Interviews